Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Wolfs

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|September 28, 2011
Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisationI M J Wolfs, M M P C Donners, M P J de Winther
Handbook of Experimental Pharmacology|January 16, 2007
TRP channels in lymphocytesE C Schwarz, M J Wolfs, S Tonner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2010
A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosisMarjo M P C Donners, Ine M J Wolfs, Servé Olieslagers, et al.
Plos One|May 5, 2012
Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic miceMarjo M P C Donners, Ine M J Wolfs, Lauran J Stöger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 18, 2013
Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosisIne M J Wolfs, J Lauran Stöger, Pieter Goossens, et al.
Scientific Reports|September 17, 2017
Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progressionKosta Theodorou, Emiel P C van der Vorst, Marion J Gijbels, et al.
Thrombosis and Haemostasis|July 1, 2016
Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxesJ Lauran Stöger, Marieke C S Boshuizen, Gemma Brufau, et al.
The American Journal of Pathology|February 10, 2015
Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosisEmiel P C van der Vorst, Mike Jeurissen, Ine M J Wolfs, et al.
Cell Metabolism|November 22, 2016
High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 SignalingEmiel P C van der Vorst, Kosta Theodorou, Yongzheng Wu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|September 28, 2011
Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisationI M J Wolfs, M M P C Donners, M P J de Winther
Handbook of Experimental Pharmacology|January 16, 2007
TRP channels in lymphocytesE C Schwarz, M J Wolfs, S Tonner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2010
A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosisMarjo M P C Donners, Ine M J Wolfs, Servé Olieslagers, et al.
Plos One|May 5, 2012
Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic miceMarjo M P C Donners, Ine M J Wolfs, Lauran J Stöger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 18, 2013
Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosisIne M J Wolfs, J Lauran Stöger, Pieter Goossens, et al.
Scientific Reports|September 17, 2017
Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progressionKosta Theodorou, Emiel P C van der Vorst, Marion J Gijbels, et al.
Thrombosis and Haemostasis|July 1, 2016
Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxesJ Lauran Stöger, Marieke C S Boshuizen, Gemma Brufau, et al.
The American Journal of Pathology|February 10, 2015
Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosisEmiel P C van der Vorst, Mike Jeurissen, Ine M J Wolfs, et al.
Cell Metabolism|November 22, 2016
High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 SignalingEmiel P C van der Vorst, Kosta Theodorou, Yongzheng Wu, et al.
Pageof 1